Clinical trial
A Multi-center, International Prospective Follow up Study to Assess the Safety and Efficacy of the iTind Procedure After Three to Five Years of Follow Up
NCT04579913 is registered in ClinicalTrials.gov with Medi-Tate Ltd. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multi-center, International Prospective Follow up Study to Assess the Safety and Efficacy of the iTind Procedure After Three to Five Years of Follow Up
- Lead sponsor
- Medi-Tate Ltd.
- Phase
- Observational
- Overall status
- Terminated
- Start date
- December 21, 2020
- Completion date
- April 22, 2021
- Enrollment
- 17 (actual)
- Sites
- 5
Conditions
As the registry lists them; a condition with its own page is linked.
benign prostatic hyperplasia (bph)